Department of Internal Medicine, Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Göteborg, S-413 45 Sweden.
Respir Med. 2010 Mar;104(3):337-44. doi: 10.1016/j.rmed.2009.10.017. Epub 2009 Nov 11.
The aim of this study was to compare female and male asthmatics with special emphasis on reported adherence, anxiety, and quality of sleep. The study included 470 subjects with current asthma from the Nordic countries, who took part in the European Community Respiratory Health Survey (ECRHS) II. Subjects were investigated with a structured clinical interview, including questions on the presence of respiratory symptoms and therapy. They were also asked to fill in the self-reported Hospital Anxiety Depression scale and the Basic Nordic Sleep Questionnaire. Inhaled corticosteroids (OR=0.55) and a doctor's appointment in the last 12 months (OR=0.54) implied a significantly reduced risk for non-adherence in normal situations. At exacerbation in asthma, women had a significantly decreased risk for non-adherence (OR=0.46). Female gender and anxiety were independent risk factors for both insomnia (OR=3.67 and 2.53, respectively) and daytime sleepiness (OR=2.53 and 2.04, respectively). Women with asthma have a more positive attitude towards their medication, have a higher reported adherence, and use inhaled corticosteroids more often than men. At the same time women report more often anxiety and insomnia than men. Awareness of sex differences in the manifestations and attitudes towards treatment of asthma is important in order to improve asthma management.
本研究旨在比较女性和男性哮喘患者,特别强调报告的依从性、焦虑和睡眠质量。该研究纳入了来自北欧国家的 470 名现患哮喘患者,他们参加了欧洲社区呼吸健康调查(ECRHS)II。通过结构化临床访谈对受试者进行调查,包括呼吸症状和治疗情况。还要求他们填写自我报告的医院焦虑抑郁量表和基本北欧睡眠问卷。在正常情况下,吸入皮质类固醇(OR=0.55)和在过去 12 个月内看医生(OR=0.54)提示依从性显著降低的风险。在哮喘恶化时,女性不依从的风险显著降低(OR=0.46)。女性性别和焦虑是失眠(OR=3.67 和 2.53)和日间嗜睡(OR=2.53 和 2.04)的独立危险因素。哮喘女性对药物的态度更积极,报告的依从性更高,且比男性更常使用吸入皮质类固醇。同时,女性比男性更常报告焦虑和失眠。了解哮喘治疗表现和态度方面的性别差异对于改善哮喘管理非常重要。